Query of firearm coaching may absolve actor of negligence, says trial legal professional

Litigation attorney Jeff Harris said that an issue of negligence on the “Rust” film set after the Fatal shooting of cameraman Halyna Hutchins could come down to the level of gun training that actor Alec Baldwin received.

“It may ultimately boil down to whether or not the actor was adequately trained in the use of firearms and that would fall on the production company and absolve Baldwin of negligence,” said Harris, who does not represent any party involved in the incident.

Baldwin’s production company El Dorado Pictures produced the upcoming film. Neither Baldwin nor El Dorado Pictures responded immediately to CNBC’s request for comment.

The assistant director who handed Alec Baldwin a loaded gun on the set admitted to investigators that he didn’t check the revolver carefully enough, according to a search warrant released on Wednesday. So did the Santa Fe County Sheriff confirmed on Wednesday that there was a real bullet in Baldwin’s revolver and that investigators found even more alleged live rounds on the set.

Harris was the lead trial attorney on the Lan Jones v CSX case and obtained a $ 11.2 million judgment on behalf of the family of camerawoman Sarah Jones, who was killed while working on the film “Midnight Rider”.

He told CNBCs “The News with Shepard Smith” that on the set of “Rust” there was likely gross negligence.

“I honestly think that if you have a movie set where you have live ammunition mixed up with dummy ammunition and spaces, that type of activity turns into gross negligence, and I believe someone who will ultimately get into this case at least charged with criminal negligence, “said Harris.

Boks’ model on trial in 100th check towards the All Blacks

The All Blacks and Springboks will meet for the 100th time on Saturday for a test that could decide this year’s rugby championship, but which some observers see as a battle for the soul of rugby.

The game in Townsville in the north of the state of Queensland in Australia offers a strong stylistic contrast between the free-flowing, fast-paced style of the All Blacks, which relies on skill and possession, and the less adventurous game of the Springboks, which focuses on kicking and being assertive Forward play.

There is no doubt which style rugby fans like the most. Leading analysts and former coaches from around the world almost unanimously criticize the style of the Springboks, which they fear will put off rugby audiences.

Two-time All Blacks world champion coach Steve Hansen said during the series between the Springboks and the British and Irish Lions this season, “It’s not a game anyone wants to watch.”

In a column in the English Daily Mail, 2003 world champion coach Clive Woodward – never a fan of the All Blacks – applauded New Zealand for playing “real rugby”.

Commenting on South Africa’s successive defeats to Australia over the past two weekends, Woodward commented: “Last weekend I was horrified to see the sheer poverty and boredom of the South African team against Australia. Rugby shouldn’t be played that way – and it isn’t – and I’m just happy that Australia won.

“The Boks v Lions streak was little better and it should worry anyone involved in the sport that rugby is going down this path. It will be dead in five years if it does. “

The springboks defy this criticism, arguing that the end justifies the means. South Africa is the current world champion and the top ranked team in world rugby. Though the series against the Lions is considered one of the least exciting major series in recent years – between two undemanding teams – the Springboks say the win justifies their chosen style.

Flyhalf Handre Pollard made this argument when the Springboks defeated Argentina twice in rugby championship matches in South Africa.

“Everyone has their own way of playing rugby which they think is the way to go,” said Pollard. “We’re not about entertainment. The rugby test match is about winning. “

Springboks assistant coach Mzwandile Stick, who was responsible for the team’s second leg, set up a more colorful defense.

“We’re the # 1 team in the world right now, we’re world champions right now, so people keep talking about us,” said Stick. “Even if it’s positive or negative. . . it is in the nature of the position we are in. “

Where South Africa is headed now, after the two defeats to the Wallabies suggest that their strategy is not always a winning strategy, will be seen on Saturday. Against opponents who can not only defuse the high ball but also turn it against themselves, the Springboks have to have less confidence in their kick game.

South Africa coach Jacques Nienaber says that the defeats against Australia are not due to the game plan, but to the poor performance of the Boks. The game on Saturday could put the strategy to the test again.

All Blacks trainer Ian Foster expects the Springboks to be well prepared and focused on properly executing the plan.

“We have no doubt that South Africa has had a plan for this game for a long time,” said Foster. “What we have learned is not to be amazed at the intensity of the opponent’s build-up and not to lull yourself into a feeling of the past two weeks and his previous form, believing that this will be an indicator of what is on Saturday happens, “he said.


More AP sports: https://apnews.com/apf-sports and https://twitter.com/AP_Sports

Settlement Reached in Dennis Hastert Hush Cash Lawsuit Days Earlier than Trial – NBC Chicago

In the civil suit against the disgraced former speaker of the US House of Representatives Dennis Hastert, an agreement was reached on Wednesday that provisionally put an end to the year-long hush-money case just a few days before the planned trial.

Judge Robert Pilmer, presiding judge for the 23rd Judicial District of Illinois, which includes Kendall County, where the lawsuit was filed, announced Wednesday afternoon that the parties had reached a preliminary settlement after attorneys on both sides showed more than an hour ago the scheduled date were held court proceedings.

“We have agreed in principle, the terms of the agreement are confidential,” said plaintiff’s attorney Kristi Browne after the settlement was announced, adding: “It just depends on us working out a written settlement agreement.”

“I can tell you that all claims between the parties are resolved subject to execution of the settlement agreement,” she said.

Hastert’s attorney, John Ellis, declined to comment.

“I would have loved to try this case, I think it was a good case,” said Browne. “I was very confident about our case from the start, but you know this is what we did and this is a solution my client is happy with.”

The settlement came less than a week after the judge ruled that the plaintiff, referred to only as James Doe in court records, would be identified in court for the first time after the trial began. The selection of the jury should begin on September 20th.

Haster, 79, approx. 85% served a 15-month prison sentence Delivered in 2016 after pleading guilty to a crime of financial crime known as structuring: disguising banking activities by withdrawing large amounts of cash in small denominations to circumvent federal reporting requirements.

Prosecutors said Hastert broke federal banking rules by covering up his $ 1.7 million withdrawals to pay hush money to a former student he made while teaching and wrestling in the 1970s. Sexually abused a coach at Yorkville High School prior to entering politics.

That person filed a breach of contract lawsuit against Hastert in 2016, demanding the unpaid balance of the total of $ 3.5 million in hush money, approximately $ 1.8 million.

Hastert was not charged in connection with the allegations of sexual abuse in part because of the Illinois statute of limitations – within three years of the incident or three years after a minor victim reached the age of 18 – had already expired.

When asked if the judge’s decision to appoint Doe had any impact on the settlement negotiations, Browne said she was unable to disclose communications with her client. But she later said that the deal came as “a bit” of a surprise to her.

“Anything can happen anytime, cases can be settled, but I would have said a few weeks ago that I was pretty sure this case was on trial,” she said.

“Let me say this: It is never over for a victim of childhood sexual abuse. It’s never over It affects her for the rest of her life, ”said Browne. “This solves this case. This solves my client’s claims against Mr. Hastert. It resolves Mr. Hastert’s counterclaim against my client and any litigation issues between them. “

MILLENNIAL MONEY: Trial, error, and what I realized in my 20s | Enterprise

Your 20s is a time of self-exploration to gain a foothold as an adult – and likely to make some monetary mistakes.

To save you studying the hard way – and to pass some knowledge on when I get into my thirties – here are five money lessons from my last decade.


My main financial goal for several years was to go out as much as I wanted and have enough money left at the end of the month to cover the rent.

Ultimately, however, dazed mornings and meager savings turned out to be unfulfilled. My partner and I decided to set goals and plan for them. We wanted to buy a house, which meant we had to move to a cheaper city so we could start building savings.

TIP: Know your passions in order to know your goals.

Certified financial planner Pam Rodriguez in Sacramento, Calif., Suggests figuring out what you enjoy and then creating a financial plan to create more of those moments.

“Personal finances are a lot more emotional than a math equation,” says Rodriguez. “Even if the numbers have to add up, you will never take action unless you feel strong about something.”

For example, if you’re looking to buy a home to take in friends and family, figure out how much you need for a down payment and closing costs, and then work toward that savings goal over time.


For most of my 20s, my budgeting system was defined by the lack of it. At some point I soaked it up and started tracking my expenses. At first I felt like I was wearing off if I didn’t document where every penny went. But I quickly realized that a simple budget is more my style.

TIP: Choose a budgeting system that reflects your identity.

If you are a hyper-analytic person, a detailed spreadsheet might be for you. But if you’re more practical, a budgeting app can do the job.

Regardless of your budget, it is important to at least understand how much money is in and out of each month.

“When people see their expenses, they have an aha moment because they don’t know where their money is going,” says Sidney Divine, an Atlanta-certified financial planner.


Did you know that if you have a contract job and you don’t put enough money aside to cover the taxes, you may have to make monthly payments to the IRS for years? I learned that the hard way when I was in my early twenties.

TIP: Find the cause of a problem and find a solution.

In my case, the problem was ignoring my finances and not thinking about tax obligations. I solved the problem by proactively managing my budget and paying off my tax debts. It also helped get a new job that wasn’t a 1099 gig.

“You need to find out: is it the same mistake you keep making? Is it a pattern? ”Says Christine Papelian, certified financial planner in Phoenix. “If it is a new mistake, you now have the opportunity to get back on track. It is almost never too late to change a behavior or a habit. “

For example, if you have a habit of making late payments, consider setting up automatic invoice payment so you don’t have to worry about keeping track of different due dates.


Last year was a crash course in terms of instability. And while recent crises have been unusually severe, you can rest assured that unexpected financial challenges will arise as your life goes on. For example, a broken alternator on my car once used up my emergency fund, but at least I was able to avoid going into debt to cover the cost.

TIP: It is essential to save.

“Focus on building an emergency fund,” says Rodriguez. “Everyone needs one because everyone is going to have an emergency.”

Consider using a direct deposit to transfer a portion of each paycheck to an emergency savings account, or set up automatic transfers from a checking account to a savings account.


The youth can be wasted on the youth, as can their financial time horizon – at least for those who do not use it.

Despite the various mistakes I made in my 20s, saving up for retirement is an area I haven’t neglected. After seeing the power of compound interest through an annuity calculator, I quickly set up regular contributions to my 401 (k).

TIP: Use these years to top up your retirement provision.

One way or another, your 20s are going to have an impact on your retirement years. And life can get more complicated later on, especially when you buy a home and raise a family, making it harder to save for retirement. Pocketing more money now can save yourself from catching up in later years.

This column was provided to The Associated Press by the personal finance website NerdWallet. Sean Pyles is a writer at NerdWallet. E-mail: spyles@nerdwallet.com. Twitter: @SeanPyles.


NerdWallet: Budgeting 101: How to Budget Money https://bit.ly/nerdwallet-money-budgeting-101

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed in any way without permission.

Decide: Lady accused of stealing cash from Ossineke enterprise will head towards trial | Information, Sports activities, Jobs

ALPENA – Judge Thomas LaCross, who is accused of stealing a quarter of a million dollars from the business of her brother-in-law Gena Carstens from Spruce, is on trial, Judge Thomas LaCross ruled on Wednesday in the 88th District Court of Alpena.

In a trial that continued from Tuesday, a witness said Carstens had given herself two raises over eight years and diverted cash from the cash register only to eventually steal enough to move the hardware store business where she was no longer doing business.

A chartered accountant who analyzed Ossineke Building Supply’s financial records in Ossineke resumed the testimony begun Tuesday when she said that between 2010 and 2018 when the store closed, more than $ 200,000 in sales and withdrawals were made Cash drawers were missing.

According to statements, Carstens was responsible for the business’s money during those years. The inconsistencies were discovered after the shopkeepers discovered that they were missing money while searching the records for the sale of the shop.

On Wednesday, CPA Cynthia Scott said a fraud investigation into the store’s financial records revealed that Carstens increased by $ 2 an hour in 2012 and 2013.

The store owners have not approved these increases, according to Annette Carstens, co-owner of the store, who testified Tuesday.

The unauthorized increases totaled $ 35,300 in excess labor costs, Scott said. She also testified that her review revealed suspicious bills for $ 16,000 relating to a company owned by Gena Carsens’ husband.

Defense attorney Dave Funk clarified through cross-examination that Scott could not prove who had transferred the money that had not made it from the cash register to the bank account.

LaCross said Alpena County Prosecutor Cynthia Muszynski has produced more than enough evidence to tie Gena Carsens to the Circuit Court. Carstens remains free and faces a prison sentence of up to 20 years if convicted.

Get the latest news and more in your inbox

Oxford to launch human problem trial to check immune response

Caroline Nicolls will receive an injection of the Moderna Covid-19 vaccine administered by Nurse Amy Nash at Madejski Stadium in Reading, west of London, on April 13, 2021.

STEVE PARSONS | AFP | Getty Images

LONDON – Oxford University researchers announced the start of a Human Challenge study on Monday to better understand what happens when people who have already contracted the coronavirus become infected for the second time.

The researchers will investigate what kind of immune response can prevent people from becoming infected with Covid-19 again and examine how the immune system reacts to the virus a second time.

Little is currently known about what happens to people who had the virus the second time they were infected.

The experiment is carried out in two phases with different participants in each phase. The first phase is slated to begin this month and the second phase is slated to begin in summer.

In medical research, Human Challenge studies are controlled studies in which participants are intentionally exposed to a pathogen or beetle to study the effects.

“Challenge studies tell us things that other studies cannot because, unlike natural infections, they are tightly controlled,” said Helen McShane, chief investigator for the study and professor of vaccinology in the Department of Pediatrics at Oxford University.

“If we re-infect these participants, we will know exactly how their immune systems responded to the first COVID infection, when exactly the second infection occurs, and how much virus they have,” said McShane.

It is hoped that the study will help improve scientists’ basic understanding of the virus and develop tests that can reliably predict whether people will be protected.

What happens in each phase?

In the first phase, up to 64 volunteers between the ages of 18 and 30 who were previously infected naturally will be re-exposed to the virus under controlled conditions.

Researchers will oversee attendees’ care while they perform CT scans of the lungs and MRI scans of the heart while isolating in a specially designed suite for at least 17 days.

All participants must be fit, healthy and have fully recovered from their initial infection with Covid to minimize the risk.

Study participants will only be released from the quarantine unit if they are no longer infected and there is a risk of the disease spreading.

A view of the City of London on a clear day.

Vuk Valcic | SOPA pictures | LightRocket via Getty Images

In the second phase of the experiment, two different areas are examined.

“First we will very carefully define the basic immune response of the volunteers before we infect them. We will then infect them with the dose of virus selected from the first study and measure how much virus we can detect after infection. We will then.” to be able to understand what kind of immune responses protect against re-infection, “said McShane.

“Second, we will measure the immune response several times after infection so we can understand what immune response is being generated by the virus,” she added.

The entire study period is 12 months, including at least eight follow-up appointments after discharge.

“This study has the potential to change our understanding by providing high-quality data on how our immune systems react to a second infection with this virus,” said Shobana Balasingam, senior research advisor on vaccines at Wellcome, a nonprofit that funded the study.

“The results could have important implications for the future management of COVID-19, influencing not only vaccine development but research into the range of effective treatments that are also badly needed,” Balasingam said.

‘Trial of the Chicago 7’ takes prime honors at SAG Awards | Leisure

In an interview after receiving the award for The Trial of the Chicago 7, Langella described the virtual experience as much more civilized. “I’m in my slippers,” he said from New York’s Hudson Valley. “I have no pants on,” added his co-star Michael Keaton.

Eddie Redmayne, who plays Tom Hayden in the film, credited Sorkin and casting director Francine Maisler with putting together such a diverse cast of actors – including Sacha Baron Cohen, Mark Rylance, Yahya Abdul-Mateen II and Jeremy Strong – into an ensemble.

“It was like a clash of different types of music, be it jazz or rock or classical – but it all came together under Aaron. He was almost the conductor, ”said Redmayne. “It was a joy day in and day out to see these great, diverse and varied actors pull it off.”

In the television categories, the ensembles of “Schitt’s Creek” (for comedy series) and “The Crown” (for drama series) have been added to their awards. Other winners were Anya Taylor-Joy (“The Queen’s Gambit”) and Gillian Anderson (“The Crown”), Jason Sudeikis (“Ted Lasso”), Jason Bateman (“Ozark”) and Mark Ruffalo (“I know that so much is true “).

The awards tend to be the most iconic event for the Screen Actors Guild, although the union’s clash with former President Donald Trump earlier this year may have made more headlines. After the guild had prepared to expel Trump (including “The Apprentice”, “Home Alone 2”) for his role in the Capitol uprising, Trump resigned from SAG-Aftra.

‘Trial of the Chicago 7’ takes prime honors at SAG Awards | Leisure

In this video, the cast of “The Trial of the Chicago 7” accepts the Award for Outstanding Achievement by a Cast in a Movie on Sunday night during the 27th annual Screen Actors Guild Awards.

SAG Awards, via AP

JAKE COYLE Associated Press

The starry cast of Aaron Sorkin’s 1960s courtroom drama “The Trial of the Chicago 7” won the grand prize in a virtual, pre-recorded Screen Actors Guild Award on Sunday, which won Netflix the highest accolade of Hollywood actors for the first time received.

The 27th SAG Awards, presented by the Hollywood actors’ guild SAG-Aftra, were a subdued affair – and not only because the ceremony was combined virtually, without a red carpet and into a recorded, zoom-heavy, one-hour broadcast on TBS and TNT. The perceived leader of the Academy Awards – Chloé Zhao’s “Nomadland” – was not nominated for best ensemble, which makes this year’s postponed SAG Awards less of an Oscar preview than in most years.

However, winning The Trial of the Chicago 7 was the first time a streaming service film won the Guild’s Ensemble Award. Written and directed by Sorkin, The Trial of the Chicago 7 was scheduled for release in theaters by Paramount Pictures prior to the pandemic hit, which led to its sale to Netflix. The streamer is still after his first best-picture win at the Oscars.

Frank Langella, who plays the judge who led the 1969 prosecution of activists arrested during the 1968 Democratic National Convention, drew parallels between the unrest of that era and today as he accepted the award on behalf of the occupation.

“‘God give us leaders,’ said the Rev. Martin Luther King before he was shot in cold blood that day in 1968 – a profound injustice,” Langella cited events that led to those dramatized in The Trial of the Chicago 7. “The Rev. King was right. We need leaders who make us hate one another less.”

AstraZeneca points up to date part three trial knowledge

A healthcare worker prepares to inject a vaccine against AstraZeneca coronavirus disease (COVID-19).

Eloisa Lopez

AstraZeneca released updated Phase 3 trial data for its Covid-19 vaccine on Wednesday after facing accuracy issues related to a preliminary report from its U.S. study earlier this week.

The Company Now it’s said his vaccine is 76% effective in protecting against symptomatic cases of viruses. A publication released on Monday reported a symptomatic efficacy rate of 79%. The updated report claims the shot is 100% effective against serious illness and hospital stays.

A group of US health officials criticized the company over the past few days for claiming that they are collecting data to make the results seem more favorable.

The National Institute for Allergies and Infectious Diseases It was announced on Tuesday that it had been informed The UK-based company may have included information from its US results that provided an “incomplete view of efficacy data”.

AstraZeneca said at the time that the numbers were based on a “pre-determined interim analysis” and promised to share the updated analysis in the coming days.

Dr. Anthony Fauci, Chief Medical Officer and White House Director at NIAID, described the situation as “unfortunate” and said it was likely that AstraZeneca would issue a modified statement.

“This is really what you call an easy mistake as it is most likely a very good vaccine,” Fauci told ABC’s Robin Roberts on Good Morning America Tuesday. “Something like that … really creates doubts about the vaccines and maybe adds to hesitation. It wasn’t necessary.”

The updated results include data from 190 symptomatic cases in more than 32,000 participants – an increase of approximately 50 symptomatic cases studied compared to the Record published on Monday.

The results suggest that the vaccine is more effective than previously thought in patients aged 65 and over, with a newly reported efficacy rate of 85% for this population versus 80% previously reported.

AstraZeneca reiterated Wednesday that the vaccine was “well tolerated” among participants and that no safety concerns were identified.

AstraZeneca has had a separate backlash over the past few weeks Reports of blood clotting associated with the vaccinealready approved and used by dozens of countries around the world. Several European nations have suspended and then resumed use of the vaccine after independent safety reviews.

– CNBC’s Berkeley Lovelace Jr., Sam Meredith, and Steve Kopack contributed to this report.

Analysts cheer ‘surprisingly constructive’ AstraZeneca U.S. trial information

A bottle of the AstraZeneca vaccine.

Igor Petyx | KONTROLAB | LightRocket via Getty Images

Health analysts welcomed AstraZenecaThe results of the much-anticipated late-stage US study results for the Covid-19 vaccine.

The study of more than 30,000 participants in the US, Peru, and Chile found the vaccine to be a Overall effectiveness of 79% in preventing symptomatic Covid and 100% effectiveness in preventing serious illness and hospitalization.

Efficacy was consistent across ages and races, with 80% effectiveness in participants 65 and over. Known as AZD1222 and jointly developed with Oxford University, the vaccine was well tolerated and the independent data security watchdog did not find any security concerns related to the vaccine, the company said Monday.

The data exceeded expectations

In a research note, Jefferies health analyst Peter Welford described the data as “surprisingly positive”.

Adam Barker, Health Analyst at Shore Capital, said, “This is arguably the first study for AZD1222 that has shown convincing efficacy in those 65 years and older.”

This is important as there have been questions about its effectiveness in this age group. Previous studies have been hampered by fewer older participants. In this study, 20% of participants were 65 years of age or older and 60% had comorbidities, which placed them at increased risk of developing serious illnesses.

Monday’s trial data confirmed the vaccine’s safety profile. Barker said that having the data from a single study with a single-dose regimen removes the data interpretation complications seen in the past with the AstraZeneca-Oxford vaccine.

Barker added that the lack of evidence of blood clots in the study was also comforting in light of recent concerns. “We are not surprised by these data, however, as the evidence of a link between the vaccine and the blood clots was already quite weak.”

AstraZeneca said it will continue to analyze the data and prepare for the primary analysis to be submitted to the U.S. Food and Drug Administration for emergency approval in the coming weeks. The vaccine has already received conditional marketing or emergency marketing authorization in more than 70 countries on six continents.

Dosing regimen a key issue for the FDA

“I can’t understand why the regulator wouldn’t approve this,” Barker wrote, but warned that the detailed data is pending.

A key question for the FDA will be what dosage regimen it will endorse should it end up using the vaccine in an emergency.

“This study is based on dosing 4 weeks apart, but we know The effectiveness can be higher if you dose with a longer interval (up to 12 weeks) and countries like the UK have successfully used this “longer period between doses” strategy to vaccinate more people quickly, “Barker said.

So the question for the FDA is whether it will recommend giving the two doses four weeks apart – assuming this was tested in the US study – or including data from the UK and other countries suggesting a longer duration .

Welford also noted the sub-optimal dosing regimen used in this study. “The study evaluated the 4-week dosing schedule, but we have evidence that the vaccine works better with longer dosing intervals,” he said.

“The primary analysis of the UK, Brazil and South Africa Phase III clinical trials found 62% efficacy when the vaccine was given 4 to 12 weeks apart, but efficacy increased to 82% when the interval was 12 weeks has been extended. “”

In addition to the dosage, analysts also observe in detail how the vaccine protects against different variants. This is expected to be included in the data packet that will be submitted to the FDA.

When it comes to comparing today’s efficacy data with that of some other vaccine manufacturers, Welford has been warning since the first vaccine readings from Pfizer and ModernCovid-19 variants have become more and more common, so the effectiveness data for the different vaccines cannot be directly compared.

Barker added that the trial results gave the vaccine important validation. “Because of its cost and ease of storage and distribution, AZD1222 was once dubbed the ‘Vaccine for the World’. We think this is a fair label,” he wrote. “Data like this, reported today to be more conclusive about the effectiveness and safety of AZD1222, is certainly cause for celebration.”

AstraZeneca has committed to distribute the vaccine for the duration of the pandemic for no profit. The company’s shares traded 2% higher in London on Monday.